A. Passioukov
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Occupational and environmental lung diseases
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Baktiar Hasan (1 shared paper)Paul Baas (1 shared paper)John J. Welch (1 shared paper)Laurent Greillier (1 shared paper)Cecilia Oliyai (1 shared paper)Vincent Dubois (2 shared papers)André Trouet (1 shared paper)Dan Shochat (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Lung Cancer (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandFranceUnited Kingdom
In The Last Decade
A. Passioukov
15 papers receiving 194 citations
Peers
Comparison fields: 5 of 43
- Oncology 90
- Pulmonary and Respiratory Medicine 80
- Immunology 43
- Otorhinolaryngology 8
- Radiology, Nuclear Medicine and Imaging 36
Countries citing papers authored by A. Passioukov
This map shows the geographic impact of A. Passioukov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Passioukov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Passioukov more than expected).
Fields of papers citing papers by A. Passioukov
This network shows the impact of papers produced by A. Passioukov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Passioukov. The network helps show where A. Passioukov may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Passioukov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies. | 2001 | 55 |
| 2 | 2008 | 43 | |
| 3 | 2014 | 22 | |
| 4 | 2013 | 22 | |
| 5 | 2006 | 17 | |
| 6 | 2017 | 17 | |
| 7 | 2020 | 6 | |
| 8 | 2005 | 5 | |
| 9 | 2006 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2005 | 2 | |
| 12 | CPI-0004Na An extracellularly tumor-activated prodrug of doxorubicin | 2000 | 1 |
| 13 | 2010 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2013 | 1 |
About A. Passioukov
A. Passioukov is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Immunology, having authored 15 papers that have together received 198 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Oncology (90 citations), Pulmonary and Respiratory Medicine (80 citations), Immunology (43 citations), Otorhinolaryngology (8 citations) and Radiology, Nuclear Medicine and Imaging (36 citations). A. Passioukov has collaborated with scholars based in Switzerland, France and United Kingdom. Frequent co-authors include Baktiar Hasan, Paul Baas, John J. Welch, Laurent Greillier, Cecilia Oliyai, Vincent Dubois, André Trouet, Dan Shochat, R. Baurain and Thomas J. Lobl. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer, Annals of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.